Drawing for EAZY

USPTO serial 98713445

EAZY

Reviewed by CopyMark Law Group

Status 653
Filing date
Status date
Registration date
—
Examiner
GAGNER, NICHOLAS M
Law office
TMO LAW OFFICE 121

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EAZY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jessica S. Sachs

Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.100 Bloomfield Hills ParkwaySuite 200Bloomfield Hills, MI 48304

Goods and services

ClassDescriptionStatusFirst use
010Inhalers sold empty, namely, heated inhalers for therapeutic purposesACTIVE—
011Electrical power-operated vaporisers for vaporizing herbs and essences for personal or household purposesACTIVE—
021Hand operated vaporisers for personal or household purposes sold empty, including heated vaporisers for vaporising herbs and essences, not for therapeutic purposes; inhalers for personal or household purposes sold empty, not for medical or therapeutic useACTIVE—
034Oral vaporisers sold empty for smokers, including heated vaporisers for vaporising herbs and essences, not for therapeutic purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 30, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 30, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Apr 30, 2026CNSLSUSPENSION LETTER WRITTEN—
Apr 30, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 30, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 30, 2026ALIEASSIGNED TO LIE—
Apr 27, 2026ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Feb 9, 2026GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Feb 9, 2026GNSIINQUIRY TO SUSPENSION E-MAILED—
Feb 9, 2026CNSISUSPENSION INQUIRY WRITTEN—
Sep 19, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 18, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 18, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Mar 18, 2025CNSLSUSPENSION LETTER WRITTEN—
Mar 17, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 17, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 17, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 4, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2025DOCKASSIGNED TO EXAMINER—
Jan 22, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 23, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance